MIR3119-2

Across TCGA pan-cancer cohorts, MIR3119-2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR3119-2 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR3119-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3119-2 expression acts as an unfavorable survival marker.

THCA, UCEC, and STAD are the cancer types where MIR3119-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.098	0.941	<.001	126	view →
UCEC	OS	Tertile	II,III,IV	0.204	0.768	.003	72	view →
STAD	DFS	Tertile	All	0.280	0.550	.009	63	view →
KIRC	DFS	Tertile	II,III,IV	0.180	0.656	.026	54	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	45	view →
SARC	OS	Tertile	All	0.108	0.839	<.001	36	view →
COAD	DFS	Tertile	All	0.235	0.790	.010	36	view →
LIHC	DFS	Tertile	All	0.080	0.553	.004	36	view →
LUAD	OS	Tertile	All	0.307	0.834	.001	27	view →
HNSC	OS	Tertile	II,III,IV	0.196	0.710	.023	27	view →
LGG	OS	Tertile	All	0.238	0.799	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR3119-2–THCA (OS)

Open the THCA breakdown →